3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Renal Cell
6
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Hematologic Neoplasms
2
Carcinoma, Basal Cell
2
Xeroderma Pigmentosum
1
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Sjogren's Syndrome
1
Seminoma
1
Scleroderma, Systemic
1
Sarcoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Rectal Neoplasms
1
Rare Diseases
1
Psoriasis
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Interventions
Cyclophosphamide
12
fludarabine
7
Vincristine
4
Rituximab
4
Prednisone
4
Doxorubicin
4
polatuzumab vedotin
3
Specimen Handling
3
zanubrutinib
2
pirtobrutinib
2
obinutuzumab
2
glofitamab
2
cemiplimab
2
Magnetic Resonance Spectroscopy
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Cell- and Tissue-Based Therapy
2
Biopsy
2
Bendamustine Hydrochloride
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
loncastuximab tesirine
1
ibrutinib
1
iberdomide
1
fludarabine phosphate
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.